[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Definium Therapeutics Inc (DFTX)

Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,640,941
  • Shares Outstanding, K 99,698
  • Annual Sales, $ 0 K
  • Annual Income, $ -183,790 K
  • EBIT $ -193 M
  • EBITDA $ -195 M
  • 60-Month Beta 2.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 16.07

Options Overview Details

View History
  • Implied Volatility 93.33% (+3.02%)
  • Historical Volatility 127.00%
  • IV Percentile 71%
  • IV Rank 30.96%
  • IV High 162.76% on 06/03/26
  • IV Low 62.19% on 04/15/26
  • Expected Move (DTE 17) 4.82 (10.25%)
  • Put/Call Vol Ratio 0.49
  • Today's Volume 4,077
  • Volume Avg (30-Day) 4,898
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 71,663
  • Open Int (30-Day) 65,067
  • Expected Range 42.22 to 51.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.55
  • Number of Estimates 5
  • High Estimate $-0.51
  • Low Estimate $-0.58
  • Prior Year $-0.50
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.69 +116.87%
on 06/09/26
49.20 -4.39%
on 06/30/26
+22.85 (+94.46%)
since 05/29/26
3-Month
17.68 +166.06%
on 03/31/26
49.20 -4.39%
on 06/30/26
+29.54 (+168.80%)
since 03/30/26
52-Week
6.40 +635.00%
on 07/01/25
49.20 -4.39%
on 06/30/26
+40.55 (+624.81%)
since 06/30/25

Most Recent Stories

More News
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 6.61 (-3.92%)
CMPS : 14.15 (-6.10%)
GHRS : 26.88 (-5.65%)
JNJ : 253.97 (-1.76%)
DFTX : 47.04 (+1.05%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 6.61 (-3.92%)
CMPS : 14.15 (-6.10%)
GHRS : 26.88 (-5.65%)
JNJ : 253.97 (-1.76%)
DFTX : 47.04 (+1.05%)
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address...

DFTX : 47.04 (+1.05%)
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address...

DFTX : 47.04 (+1.05%)
Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.19%. September...

GOOGL : 357.37 (+1.05%)
AAPL : 289.36 (+2.70%)
SNDK : 2,273.73 (+10.89%)
ADI : 397.17 (+1.38%)
TSLA : 420.60 (+2.13%)
STX : 965.00 (-0.36%)
AMD : 580.91 (+7.68%)
DFTX : 47.04 (+1.05%)
SPY : 746.77 (+0.78%)
META : 563.29 (+0.12%)
NOC : 509.31 (+2.68%)
FRVO : 29.23 (-7.99%)
Definium Therapeutics, Inc. Announces Proposed Public Offering

Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address...

DFTX : 47.04 (+1.05%)
Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.40%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. September E-mini S&P futures...

MSTR : 86.93 (-6.20%)
GOOGL : 357.37 (+1.05%)
SNDK : 2,273.73 (+10.89%)
COIN : 146.19 (-3.60%)
STX : 965.00 (-0.36%)
AMD : 580.91 (+7.68%)
DFTX : 47.04 (+1.05%)
^BTCUSD : 59,178.77 (+0.94%)
SPY : 746.77 (+0.78%)
NOC : 509.31 (+2.68%)
FRVO : 29.23 (-7.99%)
ADSK : 194.42 (-0.42%)
Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.50%. September E-mini S&P futures...

MSTR : 86.93 (-6.20%)
AMAT : 723.00 (+4.08%)
GOOGL : 357.37 (+1.05%)
SNDK : 2,273.73 (+10.89%)
GLXY : 27.34 (-4.17%)
$IUXX : 30,276.35 (+1.68%)
COIN : 146.19 (-3.60%)
ZNU26 : 109-190 (-0.27%)
LGND : 316.09 (+0.65%)
APGE : 132.73 (+0.09%)
ESU26 : 7,527.75 (-0.27%)
STX : 965.00 (-0.36%)
Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

Study met primary and all key secondary efficacy endpoints 8.1 point Montgomery-Åsberg Depression Rating Scale (MADRS) placebo-adjusted change from baseline at Week 6...

DFTX : 47.04 (+1.05%)
Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

Company to host webcast tomorrow at 8:00 a.m. EDT

DFTX : 47.04 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Definium Therapeutics, Inc. is developing therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Definium Therapeutics Inc., formerly known as Mind Medicine Inc., is based in NEW YORK....

See More

Key Turning Points

3rd Resistance Point 51.96
2nd Resistance Point 50.58
1st Resistance Point 48.81
Last Price 47.04
1st Support Level 45.66
2nd Support Level 44.28
3rd Support Level 42.51

See More

52-Week High 49.20
Last Price 47.04
Fibonacci 61.8% 32.85
Fibonacci 50% 27.80
Fibonacci 38.2% 22.75
52-Week Low 6.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.